IL33 and pancreatic neoplasm: Japanese researcher Minaga K. identified a strong association between serum IFN-α, IL-33, and IgG4 concentrations, suggesting their potential utility as novel biomarkers for distinguishing IgG4-RD and autoimmune pancreatitis from pancreatic cancer [38].